Regeneron Pharmaceuticals (NASDAQ:REGN): Q4 Non-GAAP EPS of $7.50 beats by $0.59; GAAP EPS of $6.93 beats by $0.71.
Revenue of $2.17B (+12.4% Y/Y) beats by $70M.
https://seekingalpha.com/news/3539037-regeneron-pharmaceuticals-eps-beats-0_59-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.